drugset / Trial / NCT03767257
A Study of Colesevelam for Lenalidomide-Associated Diarrhea
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to test the safety of colesevelam and find out what effects, if any, colesevelam has on lenalidomide associated diarrhea in participants with multiple myeloma on lenalidomide maintenance.
Timeline
- Start
- 2018-12-03
- Primary completion
- 2024-11-27
- Completion
- 2024-11-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Colesevelam | Other / unclassified | 1250 mg | — |